Optimus Research Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 11 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 1593.12%
(FY 2023)
- Profit 179.17%
(FY 2023)
- Ebitda 277.64%
(FY 2023)
- Net Worth 46.77%
(FY 2023)
- Total Assets 104.04%
(FY 2023)
About Optimus Research Labs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Som Dhawan, Puneet Dhawan, and Sanchit Hans serve as directors at the Company.
- CIN/LLPIN
U01114DL2013PTC257666
- Company No.
257666
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Sep 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Optimus Research Labs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Som Dhawan  | Director | 15-Jun-2023 | Current |
| Puneet Dhawan | Director | 15-Jun-2023 | Current |
| Sanchit Hans | Additional Director | Current |
Financial Performance of Optimus Research Labs.
Optimus Research Labs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1593.12% increase. The company also saw a substantial improvement in profitability, with a 179.17% increase in profit. The company's net worth Soared by an impressive increase of 46.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Optimus Research Labs?
In 2023, Optimus Research Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Krm Ayurveda Private LimitedActive 5 years 3 monthsSom Dhawan, Puneet Dhawan and 1 more are mutual person
Karma Ayush Care Private LimitedActive 1 year 3 monthsSom Dhawan, Puneet Dhawan and 1 more are mutual person
- Karma Nutravedics Private LimitedActive 1 year 3 months
Som Dhawan and Sanchit Hans are mutual person
- A2s Real Estates Private LimitedActive 7 months 8 days
Som Dhawan and Puneet Dhawan are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Optimus Research Labs?
Unlock and access historical data on people associated with Optimus Research Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Optimus Research Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Optimus Research Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
